Literature DB >> 17443905

[Expression of RAG-1 in brain during mouse development].

Jian-Gang Sun1, Shu Han, Hua Ji, Yi Zheng, Shu-Cai Ling.   

Abstract

OBJECTIVE: To investigate the expression of recombination activating gene-1 (RAG-1) and its localization in the mouse brain during the embryonic development.
METHODS: The brain tissues of E (embryonic day) 11, E13, E15, E17, E19, P0 (the birth day) and adult mice were taken, the total RNA of brains were extracted and the changes of RAG-1 expression were detected with the method of RT-PCR. The freeze sections of brain tissues from each group were stained with immunohistochemistry method. RESULT: The expression of RAG-1 persisted from E11 to P0 brain and was steadily increased from E11 to E19; the results of RT-PCR were similar to that of immunohistochemistry. The positive-cells mainly appeared in the nucleus amygdalae, hypothalamus, thalamus and hippocampus at developmental stage. The expression began to appear in ventricular zone (VZ) and intermediate zone (IZ) of telecephalic vesicle, then gradually increased in subventricular zone (SVZ), corticle plate (CP) and subcorticle plate (SP).
CONCLUSION: The expression of RAG-1 in mouse embryonic brain tissue is higher than that in the adult mouse, which may be related to the process of neuron development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17443905     DOI: 10.3785/j.issn.1008-9292.2007.02.011

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  2 in total

1.  Impaired social recognition memory in recombination activating gene 1-deficient mice.

Authors:  Patrick O McGowan; Thomas A Hope; Warren H Meck; Garnett Kelsoe; Christina L Williams
Journal:  Brain Res       Date:  2011-02-23       Impact factor: 3.252

2.  Zika virus vertical transmission in interferon receptor1-antagonized Rag1-/- mice results in postnatal brain abnormalities and clinical disease.

Authors:  Clayton W Winkler; Chad S Clancy; Rebecca Rosenke; Karin E Peterson
Journal:  Acta Neuropathol Commun       Date:  2022-04-04       Impact factor: 7.801

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.